Format

Send to:

Choose Destination
See comment in PubMed Commons below
PLoS One. 2013;8(4):e60735. doi: 10.1371/journal.pone.0060735. Epub 2013 Apr 3.

Nanoporous CREG-eluting stent attenuates in-stent neointimal formation in porcine coronary arteries.

Author information

  • 1Department of Cardiology, Institute of Cardiovascular Research of People's Liberation Army, Shenyang Northern Hospital, Shenyang, Liaoning, China.

Abstract

BACKGROUND:

The goal of this study was to evaluate the efficacy of a nanoporous CREG-eluting stent (CREGES) in inhibiting neointimal formation in a porcine coronary model.

METHODS:

In vitro proliferation assays were performed using isolated human endothelial and smooth muscle cells to investigate the cell-specific pharmacokinetic effects of CREG and sirolimus. We implanted CREGES, control sirolimus-eluting stents (SES) or bare metal stents (BMS) into pig coronary arteries. Histology and immunohistochemistry were performed to assess the efficacy of CREGES in inhibiting neointimal formation.

RESULTS:

CREG and sirolimus inhibited in vitro vascular smooth muscle cell proliferation to a similar degree. Interestingly, human endothelial cell proliferation was only significantly inhibited by sirolimus and was increased by CREG. CREGES attenuated neointimal formation after 4 weeks in porcine coronary model compared with BMS. No differences were found in the injury and inflammation scores among the groups. Scanning electron microscopy and CD31 staining by immunohistochemistry demonstrated an accelerated reendothelialization in the CREGES group compared with the SES or BMS control groups.

CONCLUSIONS:

The current study suggests that CREGES reduces neointimal formation, promotes reendothelialization in porcine coronary stent model.

PMID:
23573278
[PubMed - indexed for MEDLINE]
PMCID:
PMC3616099
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Public Library of Science Icon for PubMed Central
    Loading ...
    Write to the Help Desk